TrialClinical pharmacology in drug development2018

Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans.

Christa F Nagy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.